Sema is a GLP-1 (glucagon-like peptide-1) receptor agonist used to treat type 2 diabetes and manage obesity. It works by enhancing insulin secretion, reducing appetite, slowing gastric emptying, and promoting a sense of fullness, leading to better blood sugar control and significant weight loss.




